Neurotrophin Gene Therapy for Sustained Neural Preservation after Deafness

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Atkinson, Patrick J ^a,b   Wise, Andrew K ^a,b   Flynn, Brianna O ^a   Nayagam, Bryony A ^a,b   Hume, Clifford R ^c   O'Leary, Stephen J ^a,b   Shepherd, Robert K ^a,b   Richardson, Rachael T ^a,b  

^a BIONICS INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; NEUROTROPHIN; NEUROTROPHIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; COCHLEA DUCT; CONTROLLED STUDY; CORTI ORGAN; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GENE EXPRESSION; GUINEA PIG; HEARING IMPAIRMENT; MALE; NERVE CELL; NERVE DEGENERATION; NERVE FIBER GROWTH; NERVE SPROUTING; NONHUMAN; OTOTOXICITY; SPIRAL GANGLION; VIRAL GENE THERAPY;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEAFNESS; FEMALE; GENETIC THERAPY; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; MALE; NEUROTROPHIN 3;

CAVIA; EPITONIUM;

EID: 84871289089     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052338     Document Type: Article

References (51)

1. Davis AC (1990) Epidemiological profile of hearing impairments: the scale and nature of the problem with special reference to the elderly. Acta Otolaryngol Suppl 476: 23-31.
2. Wilson D, Walsh P, Sanchez L, Davis A, Taylor A, et al. (1999) The epidemiology of hearing impairment in an Australian adult population. Int J Epidemiol 28: 247-252.
3. Clark GM (2003) Cochlear implants: fundamentals and applications Graeme Clark. New York: Springer.
4. Bichler E, Spoendlin H, Rauchegger H, (1983) Degeneration of cochlear neurons after amikacin intoxication in the rat. Arch Otorhinolaryngol 237: 201-208.
5. Dodson HC, Mohuiddin A, (2000) Response of spiral ganglion neurones to cochlear hair cell destruction in the guinea pig. J Neurocytol 29: 525-537.
6. Feghali JG, Lefebvre PP, Staecker H, Kopke R, Frenz DA, et al. (1998) Mammalian auditory hair cell regeneration/repair and protection: a review and future directions. Ear Nose Throat J 77: 276, 280, 282-275
7. Koitchev K, Guilhaume A, Cazals Y, Aran JM, (1982) Spiral ganglion changes after massive aminoglycoside treatment in the guinea pig. Counts and ultrastructure. Acta Otolaryngol 94: 431-438.
8. Leake PA, Hradek GT, (1988) Cochlear pathology of long term neomycin induced deafness in cats. Hear Res 33: 11-33.
9. Nadol JB Jr, Young YS, Glynn RJ, (1989) Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol 98: 411-416.
10. Hardie NA, Shepherd RK, (1999) Sensorineural hearing loss during development: morphological and physiological response of the cochlea and auditory brainstem. Hear Res 128: 147-165.
11. Ernfors P, Merlio JP, Persson H, (1992) Cells Expressing mRNA for Neurotrophins and their Receptors During Embryonic Rat Development. Eur J Neurosci 4: 1140-1158.
12. Farinas I, Jones KR, Tessarollo L, Vigers AJ, Huang E, et al. (2001) Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J Neurosci 21: 6170-6180.
13. Fritzsch B, Barbacid M, Silos-Santiago I, (1998) The combined effects of trkB and trkC mutations on the innervation of the inner ear. Int J Dev Neurosci 16: 493-505.
14. Fritzsch B, Silos-Santiago I, Bianchi LM, Fariñas I, (1997) The role of neurotrophic factors in regulating the development of inner ear innervation. Trends Neurosci 20: 159-164.
15. Ylikoski J, Pirvola U, Moshnyakov M, Palgi J, Arumae U, et al. (1993) Expression patterns of neurotrophin and their receptor mRNAs in the rat inner ear. Hear Res 65: 69-78.
16. Stankovic K, Rio C, Xia A, Sugawara M, Adams JC, et al. (2004) Survival of adult spiral ganglion neurons requires erbB receptor signaling in the inner ear. J Neurosci 24: 8651-8661.
17. Ernfors P, Duan ML, ElShamy WM, Canlon B, (1996) Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med 2: 463-467.
18. Wise AK, Richardson R, Hardman J, Clark G, O'Leary S, (2005) Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J Comp Neurol 487: 147-165.
19. Gillespie LN, Clark GM, Bartlett PF, Marzella PL, (2003) BDNF-induced survival of auditory neurons in vivo: Cessation of treatment leads to accelerated loss of survival effects. J Neurosci Res 71: 785-790.
20. Agterberg M, Versnel H, van Dijk L, de Groot J, Klis S, (2009) Enhanced Survival of Spiral Ganglion Cells After Cessation of Treatment with Brain-Derived Neurotrophic Factor in Deafened Guinea Pigs. J Assoc Res Otolaryngol 10: 355-367.
21. Glueckert R, Bitsche M, Miller JM, Zhu Y, Prieskorn DM, et al. (2008) Deafferentiation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J Comp Neurol 507: 1602-1621.
22. Leake PA, Hradek GT, Hetherington AM, Stakhovskaya O, (2011) Brain-derived neurotrophic factor promotes cochlear spiral ganglion cell survival and function in deafened, developing cats. J Comp Neurol 519: 1526-1545.
23. Richardson RT, Wise A, O'Leary S, Hardman J, Casley D, et al. (2004) Tracing neurotrophin-3 diffusion and uptake in the guinea pig cochlea. Hear Res 198: 25-35.
24. Nakaizumi T, Kawamoto K, Minoda R, Raphael Y, (2004) Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol 9: 135-143.
25. Chikar JA, Colesa DJ, Swiderski DL, Polo AD, Raphael Y, et al. (2008) Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear Res 245: 24-34.
26. Wise AK, Hume CR, Flynn BO, Jeelall YS, Suhr CL, et al. (2010) Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea. Mol Ther 18: 1111-1122.
27. Shibata SB, Cortez SR, Beyer LA, Wiler JA, Di Polo A, et al. (2010) Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp Neurol 223: 464-472.
28. Wise AK, Tu T, Atkinson PJ, Flynn BO, Sgro BE, et al. (2011) The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protection. Hear Res 278: 69-76.
29. Richardson RT, Wise AK, Thompson BC, Flynn BO, Atkinson PJ, et al. (2009) Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 30: 2614-2624.
30. Shepherd RK, Clark GM, (1985) Progressive ototoxicity of neomycin monitored using derived brainstem response audiometry. Hear Res 18: 105-110.
31. James DP, Eastwood H, Richardson RT, O'Leary SJ, (2008) Effects of Round Window Dexamethasone on Residual Hearing in a Guinea Pig Model of Cochlear Implantation. Audiol Neurootol 13: 86-96.
32. Versnel H, Agterberg MJH, de Groot JCMJ, Smoorenburg GF, Klis SFL, (2007) Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide. Hear Res 231: 1-12.
33. Agterberg MJH, Versnel H, de Groot JCMJ, Smoorenburg GF, Albers FWJ, et al. (2008) Morphological changes in spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs. Hear Res 244: 25-34.
34. Sellick P, Layton MG, Rodger J, Robertson D, (2008) A method for introducing non-silencing siRNA into the guinea pig cochlea in vivo. J Neurosci Methods 167: 237-245.
35. Keithley EM, Harris JP, (1996) Late Sequelae of Cochlear Infection. Laryngoscope 106: 341-345.
36. Raphael Y, Altschuler RA, (1991) Reorganization of cytoskeletal and junctional proteins during cochlear hair cell degeneration. Cell Motil Cytoskeleton 18: 215-227.
37. Taylor RR, Jagger DJ, Forge A, (2012) Defining the Cellular Environment in the Organ of Corti following Extensive Hair Cell Loss: A Basis for Future Sensory Cell Replacement in the Cochlea. PLoS One 7: e30577.
38. Venail F, Wang J, Ruel J, Ballana E, Rebillard G, et al. (2007) Coxsackie adenovirus receptor and alpha nu beta3/alpha nu beta5 integrins in adenovirus gene transfer of rat cochlea. Gene Ther 14: 30-37.
39. Coyne CB, Bergelson JM, (2005) CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 57: 869-882.
40. Waehler R, Russell SJ, Curiel DT, (2007) Engineering targeted viral vectors for gene therapy. Nat Rev Genet 8: 573-587.
41. Spoendlin H, (1975) Retrograde degeneration of the cochlear nerve. Acta Oto-Laryngologica 79: 266-275.
42. Landry TG (2011) Effects of chronic electrical stimulation and exogenous neurotrophins in the deafened cochlea. PhD Thesis Melbourne: The University of Melbourne.
43. Shepherd RK, Hatsushika S, Clark GM, (1993) Electrical stimulation of the auditory nerve: the effect of electrode position on neural excitation. Hear Res 66: 108-120.
44. van den Honert C, Kelsall DC, (2007) Focused intracochlear electric stimulation with phased array channels. J Acoust Soc Am 121: 3703-3716.
45. Backhouse S, Coleman B, Shepherd R, (2008) Surgical access to the mammalian cochlea for cell-based therapies. Exp Neurol 214: 193-200.
46. Lin DW, Trune DR, (1997) Breakdown of stria vascularis blood-labyrinth barrier in C3H/lpr autoimmune disease mice. Otolaryngol Head Neck Surg 117: 530-534.
47. Amalfitano A, Hauser MA, Hu H, Serra D, Begy CR, et al. (1998) Production and Characterization of Improved Adenovirus Vectors with the E1, E2b, and E3 Genes Deleted. J Virol 72: 926-933.
48. Tuinstra HM, Aviles MO, Shin S, Holland SJ, Zelivyanskaya ML, et al. (2012) Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury. Biomaterials 33: 1618-1626.
49. Dalkara D, Kolstad KD, Guerin KI, Hoffmann NV, Visel M, et al. (2011) AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa. Mol Ther 19: 1602-1608.
50. Eberling JL, Kells AP, Pivirotto P, Beyer J, Bringas J, et al. (2009) Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys. Hum Gene Ther 20: 511-518.
51. Slevin JT, Gash DM, Smith CD, Gerhardt GA, Kryscio R, et al. (2007) Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal. J Neurosurg 106: 614-620.